Table 1. General characteristics of pulmonary TB and extrapulmonary TB patients, China, 2008–2017*.
Characteristic | No. (%) patients |
Crude OR (95% CI) | p value | Adjusted OR (95% CI) | p value | ||
---|---|---|---|---|---|---|---|
Pulmonary TB | Extrapulmonary TB | Total | |||||
Sex | |||||||
M | 8,757 (70.1) | 3,736 (29.9) | 12,493 | Referent | – | Referent | – |
F |
4,089 (60.3) |
2,697 (39.7) |
6,786 |
1.55 (1.45–1.65) |
<0.01 |
1.37 (1.27–1.47) |
<0.001 |
Age group, y | |||||||
<25 | 2,024 (56.4) | 1,563 (43.6) | 3,587 | 2.51 (2.28–2.77) | <0.01 | 1.72 (1.53–1.93) | <0.001 |
25–44 | 3,539 (62.7) | 2,102 (37.3) | 5,641 | 1.93 (1.77–2.11) | <0.01 | 1.55 (1.40–1.73) | <0.001 |
45–64 | 4,078 (69.6) | 1,782 (30.4) | 5,860 | 1.42 (1.30–1.56) | <0.01 | 1.30 (1.17–1.44) | <0.001 |
≥65 |
3,205 (76.5) |
9,86 (23.5) |
4,191 |
Referent |
– |
Referent |
– |
Residence | |||||||
Urban | 9,789 (68.3) | 4,537 (31.7) | 1,4326 | Referent | – | Referent | – |
Rural |
3,057 (61.7) |
1,896 (38.3) |
4,953 |
1.34 (1.25–1.43) |
<0.01 |
1.32 (1.22–1.43) |
<0.001 |
Treatment history | |||||||
New case | 10,967 (64.2) | 6,118 (35.8) | 17,085 | Referent | – | Referent | – |
Retreated case |
1,879 (85.6) |
315 (14.4) |
2,194 |
0.30 (0.27–0.34) |
<0.01 |
0.24 (0.20–0.27) |
<0.001 |
Diabetes | |||||||
No | 12,502 (66.3) | 6,352 (33.7) | 18,854 | Referent | – | Referent | – |
Yes |
344 (80.9) |
81 (19.1) |
425 |
0.46 (0.36–0.59) |
<0.01 |
0.54 (0.41–0.70) |
<0.001 |
Culture determination | |||||||
Negative | 6,256 (54.8) | 5,152 (45.2) | 11,408 | Referent | – | Referent | – |
Positive |
6,080 (88.9) |
758 (11.1) |
6,838 |
0.15 (0.14–0.17) |
<0.01 |
0.16 (0.15–0.18) |
<0.001 |
Smear determination | |||||||
Negative | 8,343 (60.0) | 5,570 (40.0) | 13,913 | Referent | – | ||
Positive |
4,000 (95.8) |
174 (4.2) |
4,174 |
0.07 (0.06–0.08) |
<0.01 |
|
|
DST | |||||||
MDR | 684 (89.2) | 83 (10.8) | 767 | 1.25 (0.97–1.61) | 0.084 | ||
XDR | 322 (89.2) | 39 (10.8) | 361 | 1.25 (0.88–1.77) | 0.216 | ||
Other | 3,716 (91.1) | 361 (8.9) | 4,077 | Referent | – |
*DST, drug susceptibility testing; MDR, multidrug-resistant; OR, odds ratio; TB, tuberculosis; XDR, extensively drug-resistant.